Healthcare and Life Science
The emerging business models for digital therapeutics
This article was originally published at Med Device Online. Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional treatments with personalized, scalable, and cost-effective int...
Queensgate awarded funding for fourth research project with NPL
Queensgate, a brand of Prior Scientific, has won funding from Innovate UK, the UK’s innovation agency, for a fourth nanopositioning research project as part of Analysis for Innovators (A4I) program (Round 11). ...
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of their LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of lentiviral production. The ready-to-transfer system minimizes...
NHS technology reform remains too slow
As the NHS progresses with its Long-Term Plan to revolutionise patient care, can it afford to wait for decades as changes are considered, debated, and implemented? In its current form, that is highly unlikely. As satisfaction in the NHS is at an all-time low. Emergency Departments face ...
How safe will driverless car technology be by 2025?
The government aims to have driverless, or autonomous, cars on the road by 2025. With that being just over a year away, we have already seen technological developments that automate some tasks, such as partial automation in emergency braking and lane assistance installed in vehicles sin...
Don't miss your chance to enter the Cambridge Independent Science and Technology Awards 2024
The deadline is January 31.
Transforming Healthcare Podcast: CES and the opportunities for the medical and health technology sector
In this episode, host, Jay Evans is joined by Dr Bipin Patel and a special guest for this podcast, Karla Pequenino, a journalist at Publico in Portugal. ...
Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer
Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale CAMBRIDGE, UK - Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of c...
New NHS blood group genotyping test developed with BioResource launches today
From today, almost 18,000 people in England with sickle cell disorder and thalassaemia can have a world-first genetic test to better match future blood transfusions, reducing the risk of side effects. ...